Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics.

about

Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics.

Item

http://www.wikidata.org/entity/Q47607822

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Gastric cancer: immunohistoche ...... opathological characteristics.

@en

Gastric cancer: immunohistoche ...... opathological characteristics.

@nl

type

Item

label

Gastric cancer: immunohistoche ...... opathological characteristics.

@en

Gastric cancer: immunohistoche ...... opathological characteristics.

@nl

prefLabel

Gastric cancer: immunohistoche ...... opathological characteristics.

@en

Gastric cancer: immunohistoche ...... opathological characteristics.

@nl

P1476

Gastric cancer: immunohistoche ...... opathological characteristics.

@en

P2093

Annika Ålgars

http://www.w3.org/2001/XMLSchema#string

Jari Sundström

http://www.w3.org/2001/XMLSchema#string

Minnamaija Lintunen

http://www.w3.org/2001/XMLSchema#string

Naziha Mansuri

http://www.w3.org/2001/XMLSchema#string

Olli Carpén

http://www.w3.org/2001/XMLSchema#string

Raija Ristamäki

http://www.w3.org/2001/XMLSchema#string

Samu Kurki

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular characterization of gastric adenocarcinoma

HER2 testing in gastric cancer: a practical approach

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer.

EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.

P2888

s00428-017-2240-x

P304

369-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-017-2240-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

472

http://www.w3.org/2001/XMLSchema#string

P50

Eva-Maria Birkman

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29046940

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

5886993

http://www.w3.org/2001/XMLSchema#string